RNA解旋酶DDX5通过解开STAT1 mRNA的G-四链体结构促进干扰素信号转导
本研究探讨RNA解旋酶DDX5在HBV复制肝细胞中对干扰素信号的作用。DDX5通过解开STAT1 mRNA 5'UTR近端的G-四链体(rG4)结构,促进STAT1翻译,从而调控干扰素应答的动态范围;在HBV感染HepaRG细胞中敲低DDX5可降低IFN-α的抗病毒效果。
要点
- DDX5通过解旋STAT1 mRNA 5'UTR的rG4结构促进STAT1翻译。
- DDX5表达低的HCC细胞系干扰素应答减弱,DDX5缺失与STAT1缺失对应。
- HBV感染HepaRG细胞中敲低DDX5降低IFN-α抗病毒效果。
核心结论
- DDX5通过解开STAT1 mRNA 5'UTR的G-四链体结构促进STAT1翻译,是先天免疫和辅助IFN-α治疗中干扰素应答动态范围的关键调节因子。
研究设计与样本
- 采用分子、药理学和生物物理检测方法,结合HBV复制细胞模型、HCC细胞系和肝肿瘤组织进行研究。
主要发现
- DDX5通过解开STAT1 5'UTR近5'端的rG4结构调控STAT1 mRNA翻译。
- 表达低DDX5的HCC细胞系表现出干扰素应答减弱。
- 正常肝脏和肝肿瘤免疫组化显示DDX5缺失与STAT1缺失相对应。
- 在HBV感染的HepaRG细胞中敲低DDX5降低了IFN-α的抗病毒效果。
关键数值与推荐
- 使用荧光素酶报告基因检测比较野生型与突变rG4序列,rG4稳定化合物,CRISPR/Cas9编辑STAT1-rG4序列,以及圆二色谱测定rG4结构。
- STAT1-rG4编辑的细胞系对rG4稳定化合物在IFN-α应答中的效应具有抗性。
- 核糖核蛋白和电泳迁移率实验证明RNA解旋酶活性DDX5直接选择性结合野生型STAT1-rG4序列。
临床怎么用
- DDX5可能作为预测干扰素治疗应答的潜在标志物,并提示靶向DDX5或rG4结构以增强IFN-α疗效的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: RNA helicase DDX5 is downregulated during HBV replication and poor prognosis HBV-related hepatocellular carcinoma (HCC). The objective of this study is to investigate the role of DDX5 in interferon (IFN) signalling. We provide evidence of a novel mechanism involving DDX5 that enables translation of transcription factor STAT1 mediating the IFN response. DESIGN AND RESULTS: Molecular, pharmacological and biophysical assays were used together with cellular models of HBV replication, HCC cell lines and liver tumours. We demonstrate that DDX5 regulates STAT1 mRNA translation by resolving a G-quadruplex (rG4) RNA structure, proximal to the 5' end of STAT1 5'UTR. We employed luciferase reporter assays comparing wild type (WT) versus mutant rG4 sequence, rG4-stabilising compounds, CRISPR/Cas9 editing of the STAT1-rG4 sequence and circular dichroism determination of the rG4 structure. STAT1-rG4 edited cell lines were resistant to the effect of rG4-stabilising compounds in response to IFN-α, while HCC cell lines expressing low DDX5 exhibited reduced IFN response. Ribonucleoprotein and electrophoretic mobility assays demonstrated direct and selective binding of RNA helicase-active DDX5 to the WT STAT1-rG4 sequence. Immunohistochemistry of normal liver and liver tumours demonstrated that absence of DDX5 corresponded to absence of STAT1. Significantly, knockdown of DDX5 in HBV infected HepaRG cells reduced the anti-viral effect of IFN-α. CONCLUSION: RNA helicase DDX5 resolves a G-quadruplex structure in 5'UTR of STAT1 mRNA, enabling STAT1 translation. We propose that DDX5 is a key regulator of the dynamic range of IFN response during innate immunity and adjuvant IFN-α therapy.
引用
- Sun J, Wu G, Pastor F, et al. RNA helicase DDX5 enables STAT1 mRNA translation and interferon signalling in hepatitis B virus replicating hepatocytes. Gut. 2021. PMID: 34021034. doi:10.1136/gutjnl-2020-323126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。